AllDocs -> cancers

Accelerated Hyperfractionated Radiotherapy for Uterine Cervix Cancer (Cervix-II) FNCA 2003 Workshop on Radiation Oncology Suzhou(Soochow)/Shanghai, China, 2003 Page 2 Characteristics of Patients Page 3 CHN IDN JPN KOR PHL THA VNM Registered Cases n=103 MYS Cases Followed (%) 7 7 (100%) 7 5 (71%) 18 18 (100%) 33 33 (100%) Cases Followed (%) 16 8 (50%) 17 11 (65%) 5 5 (100%) 0 0 Total 103 87 (84.5%) Page 4 Characteristics of Registered Patients (n=103) Age (range) Tumor Size <4cm ...

uterine cancer UTERINE /ENDOMETRIAL CANCER What is Uterine /Endometrial Cancer ? Cancers that occur in the uterus (the hollow, pear-shaped organ in which a baby grows, also called the womb) may be from one of two sources. The most common one starts in the lining (endometrium) of the uterus. Facts: Uterine /endometrial cancer is the fourth most common cancer affecting women. Approximately 37,000 new cases are diagnosed each year. This cancer usually occurs after reproductive years, between ages 50 and 70. Causes/Risk Factors: For uterine /endometrial cancer : (the cause is not entirely clear, but may be related to levels of estrogen in the woman?s body) Age: usually women over 50 History of endometrial hyperplasia: increase in number of cells ...

REVIEW Postmodern cancer : the role of human immunodeficiency virus in uterine cervical cancer B Clarke, R Chetty . J Clin Pathol: Mol Pathol 2002;55:19–24 The association between cervical cancer and human papillomavirus (HPV) is well known, but its association with human immunodeficiency virus (HIV) is controversial. Coinfection with HPV and HIV is to be expected and recent epidemiological data from Africa show that cervical cancer is the most common AIDS defining neoplasm in women. Unlike other AIDS defining neoplasms, the occurrence of cervical cancer is not dependent on immune compromise. HIV alters the natural history of HPV infection, with decreased regression rates and more rapid progression to high grade and invasive lesions, which are refractory to treatment, requiring more stringent intervention and monitoring. The more aggressive behaviour ...

Copyright © 1998 by W.B. Saunders Company. All rights reserved. 510 A BASIC INFORMATION DESCRIPTION Cancer of the endometrium (lining of the uterus). It usually affects postmenopausal women ages 50 to 60. FREQUENT SIGNS AND SYMPTOMS Early stages: • Bleeding or spotting, especially after sexual inter- course. This often occurs after menstrual activity has ceased for 12 months or more. A watery or blood- streaked vaginal discharge may precede bleeding or spotting. • Enlarged uterus. It is sometimes a large enough mass to be felt externally. Later stages: • Spread to other organs, causing abdominal pain, chest pain and weight loss. CAUSES Unknown. Appears to be linked to several predisposing factors listed in Risk. RISK INCREASES WITH • Diabetes mellitus. • Obesity. • High blood pressure. • Use of estrogen without ...

Web Immagini Gruppi Directory News Ricerca avanzata Preferenze Cerca nel Web Cerca solo le pagine in Inglese Spiacenti, nessun contenuto associato a questo URL Web La ricerca di - cache:_9ndRDN_pNAJ:www.cancercouncil.com.au/html/research/researchreports/survival/downloads/uterine.pdf allintitle: uterine cancer filetype:pdf OR filetype:doc OR filetype:ppt OR filetype:xls OR filetype:rtf - non ha prodotto risultati in nessun documento. Suggerimenti: - Assicurarsi che tutte le parole siano state digitate correttamente. - Provare con parole chiave diverse. - Provare con parole chiave più generiche. - Provare con un numero minore di parole chiave. ...

uterine cancer UTERINE CANCER A Service of the Long Beach V A M C Patient Education Series 1998 What Is This? Cancer of the lining of the uterus. It usually affects postmenopausal women ages 50-60. How Can I Know If I Have This? Early stages: Bleeding or spotting, especially after sexual intercourse. This often occurs after menstrual activity has ceased for 12 months or more. Enlarged uterus. Later stages: Spread to other organs, causing abdominal pain, chest pain and weight loss. What Causes This? Unknown. You Are More Likely To Get This If: Diabetes mellitus. Obesity. High blood pressure. Use of estrogen without also using progesterone. Family history of breast or ovarian cancer . History of uterine polyps, menstrual cycles without ovulation, or ...

UTERINE SARCOMA - CANCER SITES UTERINE SARCOMA What Is Cancer ? Cancer develops when cells in a part of the body begin to grow out of control. Although there are many kinds of cancer , they all start because of out-of-control growth of abnormal cells. Normal body cells grow, divide, and die in an orderly fashion. During the early years of a person's life, normal cells divide more rapidly until the person becomes an adult. After that, cells in most parts of the body divide only to replace worn-out or dying cells and to repair injuries. Because cancer cells continue to grow and divide, they are different from normal cells. Instead of dying, they outlive normal cells and continue to form new abnormal cells. Cancer cells often travel to other parts of the body where they begin to grow and replace normal tissue. This process, called metastasis, occurs as the cancer cells ...

research for a cure laboratory without walls National Foundation for Cancer Research Cancer FAQs about uterine cancer Frequently Asked Questions about common cancers. Page 2 Cancer FAQs What are the risk factors for endometrial cancer ? Most of the known risk factors for endometrial cancer appear to be related to changes in the balance between estrogen and progesterone, the two main female hormones. During a woman’s childbearing years, levels of each of these hormones shift on a monthly cycle, producing changes in the thickness of the endometrium. When the menstrual cycle begins, the endometrium is very thin, consisting only of a few layers of cells. But for the first 14 days of a woman’s menstrual cycle, the ovaries produce more and more estrogen, which causes endometrial cells to proliferate (grow). ...

Abstract. The development of carcinoma is associated with alterations in the expression of many cell adhesion molecules. Syndecan-1 is a cell surface proteoglycan that binds cells to the extracellular matrix and changes its expression following malignant transformation in some tumors. Our purpose was to examine the pattern of syndecan-1 expression in cancer of the uterine cervix and assess the clinicopathological significance of syndecan-1 expression. A total of 106 tissue specimens (6 normal, 19 cervical intraepithelial neoplasia (CIN) and 81 invasive cancer ) were analyzed immunohistochemically. In addition, the corresponding expression of mRNA in tumor tissues was evaluated by reverse transcription-polymerase chain reaction (RT/PCR) in comparison with normal counterparts. Syndecan-1 was positive in normal squamous cells except the basal cell layer. The intensity of syndecan-1 staining ...

REVIEW ARTICLE CURRENT SCIENCE, VOL. 78, NO. 1, 10 JANUARY 2000 52 Cancer of the uterine cervix and human papillomavirus infection B. C. Das*, V. Gopalkrishna, Suresh Hedau and Sanjay Katiyar Division of Molecular Oncology, Institute of Cytology and Preventive Oncology (ICMR), Maulana Azad Medical College Campus, Bahadur Shah Zafar Marg, New Delhi 110 002, India Human papillomaviruses (HPVs) have emerged as the principal sexually transmitted causal agents in the development of cancer of the uterine cervix in women. They also cause a variety of benign lesions, warts, intraepithelial neoplasia and anogenital, oral and pharyngeal papillomas. Presently, more than 100 HPV genotypes have been identified in humans, and about one-third ...

305 Volume 17, Number 4 ORIGINAL ARTICLE ORIGINAL ARTICLE Radiation Medicine: Vol.17 No.4, 305–309 p.p., 1999 Angiographic Changes in Uterine Cervical Cancer during the Course of Transarterial Infusion Chemotherapy Hidekazu Saitoh,* Yasushi Nagata,* Michihide Mitsumori,* Masaki Kokubo,* and Masahiro Hiraoka* Purpose: To assess the correlation between angiographic findings, tumor stage, tumor size, histological type, and the effect of transcatheter arterial infusion (TAI) chemotherapy in patients with uterine cervical cancer . Materials and Methods: Thirty-three patients with untreated cervical cancer underwent two cycles of TAI. Changes in angiographic findings and other clinical and imaging data were assessed using the ? 2 test, multivariate analysis, and the two-sample t-test. Results: The group with parametric involvement ...

Abstract. Lumican is a member of a small leucine-rich proteoglycan (SLRP) family and is reported to be over- expressed during the wound healing process of the cornea, and ischemic and reperfused heart. In the carcinomatous tissues, lumican is overexpressed in human breast and pancreatic cancer tissues. In the present study, we aimed to clarify the expression of lumican mRNA and its protein in human cervical cancer cell lines (CaSki, ME-180 and HeLa cells) and their localization in normal and cancerous human cervical tissues. Reverse transcription-polymerase chain reaction and Western blot analysis revealed the expression of lumican mRNA and its protein in CaSki, ME-180 and HeLa cells. No or weak immunoreactivity of the lumican protein was observed in stroma but not in squamous and ductal cells of non-cancerous uterine cervical tissues. In 21 of 28 (75%) cervical cancer cases, the ...

AbstractID: 6615 Title: Influence of ovoid shields and geometry of insertion on doses to critical structures in Fletcher-Suit intracavitary application For the treatment of uterine cervix cancer , boost dose is delivered using intracavitory brachytherapy. This mode of treatment often involves high dose to the critical structures such as anterior rectal wall and the bladder. The rectal and bladder tolerances are very important while using High Dose Rate (HDR) brachytherapy. In order to reduce dose to these critical structures the Fletcher-Suit applicator used for intracavitary treatments is designed with a shields on ovoids. However, there is no published data in the literature on quantitative reduction of doses to critical organs due to the shields. Plus the effectiveness of these shields if the quality of intracavitory insertion is suboptimal. In view of these uncertainties the dosimetry data in 30 intracavitory ...

ENDOMETRIAL ( UTERINE ) CANCER - All Sections ENDOMETRIAL ( UTERINE ) CANCER What Is Cancer ? Cancer is a group of many related diseases. All forms of cancer cause cells in the body to change and grow in an abnormal way. Normal body cells divide and grow in an orderly fashion. But cancer cells divide and grow out of control. This out-of-control growth damages normal body tissues and disrupts the ability of organs to function as they should. During the early years of a person's life, normal cells divide more rapidly until adult size is reached. After that, normal cells of most tissues divide only to replace worn-out tissue and to repair injuries. Cancer cells, however, continue to grow. Often the cells form tumors (lumps) that compress, invade, and destroy normal tissue. Unless the cancer is treated, the tumors can grow and spread. If cells break away from ...

Let's Make Cancer History 1 8 8 8 9 3 9 - 3 3 3 3 I w w w. c a n c e r. c a Uterine Cancer What you need to know Page 2 UTERINE CANCER What you need to know Even though we hear about cancer almost every day, when you are diagnosed with cancer you may feel alone and afraid. You may also feel overwhelmed by all the information you are given and by the need to make so many decisions. This publication will give you and your family introductory information you need when you first learn that you have uterine cancer (endometrial cancer ) 1 . It will help you gain a sense of control and help you work with your healthcare team to choose the best treatments for you. 1 The information in this publication is about cancer of the lining of ...

Center for Environmental Health Studies (617) 482-9485 44 Farnsworth Street, Boston, MA 02210 http://www.jsi.com Cervical and Uterine Cancer and Exposure to Ionizing Radiation 1 Cervical and Uterine Cancer and Exposure to Ionizing Radiation Summary: Moderate evidence has been recorded of a possible connection between cervical and uterine cancers and exposure to ionizing radiation. This evidence is based upon studies of nuclear workers and others exposed to ionizing radiation. The National Research Council’s has not determined whether the uterus is sensitive to ionizing radiation. Cervical and uterine cancers are not designated as “specified” cancers under the Energy Employees Occupational Illness Compensation Program Act. Historically, cervical cancer incidence and mortality have been low in Los Alamos County and high in Rio Arriba County among New ...

Composite hat Women Need to Know • Other things that increase your risk for uterine cancer include: ~ diabetes ~ gall bladder disease ~ high blood pressure ~ being overweight • One way to reduce the added risk from estrogen replacement therapy is to add the hormone progesterone to the therapy. • Getting pregnant or using birth control pills appear to protect against cancer of the uterus lining. • Some women with a family history of colon cancer also may be more likely to get ovarian cancer and cancer of the lining of the uterus. How can I detect uterine cancer early? • Women 40 and over should get an annual pelvic exam. Younger women should have a pelvic exam at the same time as their Pap test for cervical cancer . • Women at ...

71 Cancer of the Uterine Cervix 12 12.1. INTRODUCTION AND SUMMARY The registration and classification of cancer of the cervix is more difficult than that of other cancers, as the majority of cancers of the cervix are very early lesions detected because of screening. Opinions differ on whether these lesions are cancerous or pre-cancerous, and on their likelihood of progressing, without treatment, to invasive cancer . The National Cancer Registry’s policy is to register all cancers of the cervix, including CIN III, regardless of type, if they have been verified by histology. However, the lesions registered as "in situ" below would not be registered as " cancer " by the majority of cancer registries and are not included in international comparisons. Invasive cancers of the cervix make up only a small proportion of female cancers (1.8%) (Table 12.1). Mortality for invasive cancers ...

Body of uterus Cancer survival, incidence and mortality in NSW 1994–2000 42 The Cancer Council NSW Uterine cancer • The five-year relative survival from uterine cancer in NSW between 1994 and 2000 was 79.8% • No Area Health Service was different from the State average in the adjusted relative risk of excess death after shrinking • An additional 14 patients would be expected to survive to five years after diagnosis in NSW if the State average risk was shifted to the 20 th centile of the distribution • There were 2,179 new cases of uterine cancer in NSW in 1994 to 1998 and 469 deaths • There were no Area Health Services in which the number of new cases of uterine cancer was different from expected, and there was no area variation in the excess number of deaths from uterine cancer Table 19a: Five-year relative survival, ...

REG-8 REG-7 REG-6 REG-5 REG-4 REG-3 REG-2 REG-1 WYOMING *** ORLEANS *** NIAGARA GENESEE *** ERIE CHAUTAUQUA CATTARAUGUS ALLEGANY *** YATES *** WAYNE *** STEUBEN SENECA *** SCHUYLER *** ONTARIO *** MONROE LIVINGSTON *** CHEMUNG TOMPKINS *** ST. LAWRENCE OSWEGO ONONDAGA ONEIDA MADISON *** LEWIS *** JEFFERSON *** HERKIMER *** CORTLAND *** CAYUGA *** TIOGA CHENANGO *** BROOME WASHINGTON *** WARREN *** SCHOHARIE *** SCHENECTADY *** SARATOGA *** RENSSELAER *** OTSEGO *** MONTGOMERY *** HAMILTON GREENE *** FULTON *** FRANKLIN *** ESSEX *** DELAWARE *** COLUMBIA *** CLINTON *** ALBANY WESTCHESTER ULSTER SULLIVAN ROCKLAND PUTNAM ORANGE DUTCHESS RICHMOND QUEENS ...